- Home
- VNDA vs EVM Comparison
VNDA vs EVM Comparison
Compare VNDA & EVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- EVM
- Stock Information
- Founded
- VNDA 2002
- EVM 2002
- Country
- VNDA United States
- EVM United States
- Employees
- VNDA N/A
- EVM N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- EVM Finance/Investors Services
- Sector
- VNDA Health Care
- EVM Finance
- Exchange
- VNDA Nasdaq
- EVM Nasdaq
- Market Cap
- VNDA 237.9M
- EVM 219.2M
- IPO Year
- VNDA 2006
- EVM N/A
- Fundamental
- Price
- VNDA $4.34
- EVM $8.79
- Analyst Decision
- VNDA Strong Buy
- EVM
- Analyst Count
- VNDA 3
- EVM 0
- Target Price
- VNDA $15.33
- EVM N/A
- AVG Volume (30 Days)
- VNDA 519.0K
- EVM 55.8K
- Earning Date
- VNDA 05-07-2025
- EVM 01-01-0001
- Dividend Yield
- VNDA N/A
- EVM 4.01%
- EPS Growth
- VNDA N/A
- EVM N/A
- EPS
- VNDA N/A
- EVM 0.20
- Revenue
- VNDA $201,351,000.00
- EVM N/A
- Revenue This Year
- VNDA $16.86
- EVM N/A
- Revenue Next Year
- VNDA $39.78
- EVM N/A
- P/E Ratio
- VNDA N/A
- EVM $47.61
- Revenue Growth
- VNDA 13.37
- EVM N/A
- 52 Week Low
- VNDA $3.81
- EVM $7.67
- 52 Week High
- VNDA $6.75
- EVM $9.59
- Technical
- Relative Strength Index (RSI)
- VNDA 51.79
- EVM 37.06
- Support Level
- VNDA $4.17
- EVM $8.81
- Resistance Level
- VNDA $4.41
- EVM $8.93
- Average True Range (ATR)
- VNDA 0.16
- EVM 0.09
- MACD
- VNDA 0.03
- EVM -0.01
- Stochastic Oscillator
- VNDA 73.61
- EVM 16.67
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About EVM Eaton Vance California Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance California Municipal Bond Fund is an investment company with an objective to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in its specified state. The company provides its solutions to individual investors, institutional investors, high net worth individuals, family office investors, and financial professionals. It offers a range of equity, income and alternative strategies to institutional investors, both in the United States and internationally.